Abstract
Despite a century of intensive investigation, the underlying cause of multiple sclerosis has eluded us. It is clear that there exists a prominent progressive degenerative phenotype together with an important autoimmune inflammatory component, and careful histopathological examination always shows, to a greater or lesser degree, concomitant degeneration/demyelination and adaptive T cell-dependent immune responses. Given this picture, it is difficult, if not impossible, to definitively say whether degeneration or autoimmunity is the initiator of the disease. In this review, I put forward the evidence for and against both models and speculate that, in contrast to the accepted view, it is equally likely that multiple sclerosis may be a degenerative disease that secondarily elicits an autoimmune response, and suggest how this might influence therapeutic approaches. © 2013 Faculty of 1000 Ltd.
Cite
CITATION STYLE
Stys, P. K. (2013). Pathoetiology of multiple sclerosis: Are we barking up the wrong tree? F1000Prime Reports, 5. https://doi.org/10.12703/P5-20
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.